This study reports the severity of clinical lupus nephritis (LN), defi
ned as the sustained presence of proteinuria and/or cellular casts, in
a group of 68 newly diagnosed patients with systemic lupus.erythemato
sus (SLE) in Curacao. Fifty-four patients (78%) developed clinical sig
ns of LN, of whom 31 (54%) had clinical LN at the time of SLE diagnosi
s. The probability of developing clinical LN reached 80% in the first
3 years after SLE diagnosis and hardly increased later. No clinical or
serological differences existed at the time of SLE diagnosis or at on
set of LN between patients with early-or late-onset LN. Survival in pa
tients without LN was 100% at 5 years, while for patients with clinica
l LN these rates at 1 and 5 years were 91% and 59%, respectively (P =
0.0001); male LN patients had a worse prognosis than females (P = 0.01
2), while time of LN onset did not influence survival. Six patients (1
1%) developed end-stage renal failure; all were female, rive had early
LN and one had late-onset LN (P = 0.17). Renal survival was 97% and 8
0% at 1 and 5 years, with decreased rates for patients with nephrotic-
range proteinuria (P = 0.02). Hypertension was present in 13% of LN pa
tients, but had no influence on patient or renal survival. Thus, clini
cal LN was a frequent complication, which carried a poor prognosis in
these Afro-Caribbean lupus patients.